Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$16.27 - $20.51 $162,700 - $205,100
-10,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$12.61 - $22.33 $126,100 - $223,299
10,000 New
10,000 $208,000
Q4 2018

Feb 14, 2019

SELL
$12.41 - $22.98 $219,470 - $406,401
-17,685 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$2.45 - $16.27 $43,328 - $287,734
17,685 New
17,685 $288,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $238M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.